XML 93 R69.htm IDEA: XBRL DOCUMENT v3.8.0.1
TriVascular Merger (Pro-Forma Information) (Details) - TriVascular Technologies, Inc. - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2017
Dec. 31, 2015
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Business Acquisition [Line Items]          
Pro forma net loss from continuing operations       $ 195,596 $ 195,605
Pro forma net loss from continuing operations       $ (150,054) $ (113,534)
Pro forma basic net loss per share (in dollars per share) $ (0.30) $ (0.37)   $ (1.82) $ (1.40)
Pro forma diluted net loss per share (in dollars per share) $ (0.30) $ (0.37) $ (1.82) $ (1.40)